GUGGENHEIM CAPITAL LLC - BEAM THERAPEUTICS INC ownership

BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 226 filers reported holding BEAM THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.

Quarter-by-quarter ownership
GUGGENHEIM CAPITAL LLC ownership history of BEAM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,683,332
-38.9%
69,993
-18.9%
0.01%
-36.4%
Q2 2023$2,756,899
+10.8%
86,342
+6.3%
0.02%
+4.8%
Q1 2023$2,487,508
-27.6%
81,238
-7.5%
0.02%
-30.0%
Q4 2022$3,436,126
-17.6%
87,858
+0.4%
0.03%
-21.1%
Q3 2022$4,169,000
+11.1%
87,530
-9.7%
0.04%
+26.7%
Q2 2022$3,752,000
-28.3%
96,939
+6.1%
0.03%
-3.2%
Q1 2022$5,234,000
-26.3%
91,336
+2.4%
0.03%
-16.2%
Q4 2021$7,104,000
+12.9%
89,154
+23.3%
0.04%
-2.6%
Q3 2021$6,291,000
+96.7%
72,308
+191.0%
0.04%
+100.0%
Q2 2021$3,198,00024,8450.02%
Other shareholders
BEAM THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
MWG Management Ltd. 2,362,635$205,573,00024.93%
HSG Holding Ltd 796,089$69,268,0006.22%
DC Investments Management, LLC 21,010$1,828,0003.41%
Redmile Group, LLC 1,975,006$171,845,0003.00%
Casdin Capital, LLC 818,820$71,246,0001.77%
Evolutionary Tree Capital Management, LLC 44,390$3,862,0001.71%
HHLR ADVISORS, LTD. 1,448,161$126,004,0001.65%
Nan Fung Group Holdings Ltd 54,903$4,777,0001.53%
ARK Investment Management 6,841,722$595,298,0001.43%
BRANDYWINE MANAGERS, LLC 12,900$1,122,0001.17%
View complete list of BEAM THERAPEUTICS INC shareholders